Henry Ford Health's recent financial performance reveals a critical disconnect that every healthcare marketing leader should understand: revenue growth doesn't guarantee operational health. When a major health system sees revenue increases driven by joint ventures while operating margins compress, i

When a Chief Investment Officer departs after a decade at one of the nation's most prestigious health systems, it's easy to dismiss it as routine executive churn. But for healthcare marketers, these transitions reveal critical intelligence about institutional strategy, budget priorities, and where o

If your healthcare organization has ramped up telehealth services or digital marketing in the GLP-1 weight loss space, the FDA just drew a bright red line you cannot cross. On March 3, 2026, the agency issued 30 warning letters to telehealth companies for false or misleading claims about compounded

A Louisiana hospital just opened a $3 million interventional radiology suite, and if your marketing team learned about it from a press release after the ribbon-cutting, you've already lost six months of patient acquisition opportunity. Capital investments in specialty service lines aren't just facil

Brown Health's -1.5% operating margin in Q1 isn't just a finance problem—it's a marketing mandate. When healthcare systems operate in the red, CMOs and marketing leaders face an uncomfortable truth: your patient acquisition costs, campaign ROI, and attribution models are about to undergo intense CFO

When a health system acquires a new hospital, the C-suite focuses on clinical integration, EHR consolidation, and operational synergies. But here's what most integration playbooks ignore: your newly acquired facility comes with established patient relationships, community trust, and brand equity tha

When a healthcare system asks the state for help meeting payroll, it's not just a finance problem—it's a reputation crisis that demands immediate marketing strategy adjustments. Financial distress at healthcare organizations doesn't happen in a vacuum, and for marketing leaders, the early warning si

Healthcare marketers face a double bind in 2026: geopolitical instability threatens the generic drug supply chain while the FDA simultaneously intensifies enforcement against misleading pharmaceutical marketing. This convergence creates both risk and opportunity—organizations that navigate drug avai

WellSpan's reported 21.5% reduction in post-acute spending signals more than operational efficiency—it exposes a fundamental vulnerability in most healthcare marketing strategies. While health systems obsess over patient acquisition at the front door, they're hemorrhaging revenue and continuity thro

The $118 million Aetna settlement for Medicare Advantage upcoding allegations isn't just another regulatory headline—it's a critical wake-up call for healthcare marketers who've been pushing aggressive enrollment tactics without adequate compliance guardrails. When payers face nine-figure penalties